Taysha Gene Therapies (TSHA) Short Interest Ratio & Short Volume $2.76 -0.06 (-1.96%) As of 11:50 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Taysha Gene Therapies Short Interest DataTaysha Gene Therapies (TSHA) has a short interest of 43.96 million shares. This marks a 2,952.78% increase in short interest from the previous month. The short interest ratio (days to cover) is 11.4, indicating that it would take 11.4 days of the average trading volume of 2.86 million shares to cover all short positions.Current Short Interest43,960,000 sharesPrevious Short Interest1,440,000 sharesChange Vs. Previous Month+2,952.78%Dollar Volume Sold Short$110.34 millionShort Interest Ratio11.4 Days to CoverLast Record DateJuly 15, 2025Outstanding Shares214,660,000 sharesPercentage of Shares Shorted20.48%Today's Trading Volume431,667 sharesAverage Trading Volume2,863,206 sharesToday's Volume Vs. Average15% Short Selling Taysha Gene Therapies? Sign up to receive the latest short interest report for Taysha Gene Therapies and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartTSHA Short Interest Over TimeTSHA Days to Cover Over TimeTSHA Percentage of Float Shorted Over Time Taysha Gene Therapies Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/15/202543,960,000 shares $110.34 million +2,952.8%N/A11.4 $2.51 6/30/20251,440,000 shares $3.33 million -95.7%0.7%2.3 $2.31 6/15/202533,270,000 shares $84.51 million +4.0%16.1%8.8 $2.54 5/31/202531,980,000 shares $86.67 million +21.9%16.0%9.4 $2.71 5/15/202526,240,000 shares $67.17 million +0.7%13.2%9.5 $2.56 4/30/202526,060,000 shares $50.56 million +12.6%N/A10.8 $1.94 4/15/202523,150,000 shares $29.40 million +7.0%11.6%10.8 $1.27 3/31/202521,630,000 shares $30.07 million -14.3%10.8%9.8 $1.39 3/15/202525,250,000 shares $43.43 million -1.1%12.7%12.5 $1.72 2/28/202525,530,000 shares $40.85 million +1.8%12.8%10.9 $1.60 Get the Latest News and Ratings for TSHA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Taysha Gene Therapies and its competitors with MarketBeat's FREE daily newsletter. 2/15/202525,090,000 shares $40.90 million +4.2%12.6%8.1 $1.63 1/31/202524,080,000 shares $36.12 million +0.5%N/A5.7 $1.50 1/15/202523,950,000 shares $39.04 million -7.5%N/A5.4 $1.63 12/31/202425,880,000 shares $44.77 million +18.3%N/A6 $1.73 12/15/202421,880,000 shares $45.29 million +39.6%N/A5.1 $2.07 11/30/202415,670,000 shares $50.77 million -0.5%N/A3.8 $3.24 11/15/202415,750,000 shares $32.45 million -10.7%N/A4.4 $2.06 10/31/202417,640,000 shares $29.81 million -14.8%N/A8.1 $1.69 10/15/202420,700,000 shares $40.37 million +0.3%N/A13.9 $1.95 9/30/202420,640,000 shares $41.49 million +4.1%N/A13.7 $2.01 9/15/202419,830,000 shares $45.41 million -8.5%N/A9.5 $2.29 8/31/202421,660,000 shares $48.52 million +4.2%N/A9.5 $2.24 8/15/202420,780,000 shares $47.59 million -10.5%N/A8.3 $2.29 7/31/202423,210,000 shares $51.29 million +11.5%N/A8.9 $2.21 7/15/202420,810,000 shares $50.78 million +54.7%N/A7.9 $2.44 6/30/202413,450,000 shares $30.13 million -8.6%N/A4.9 $2.24 6/15/202414,720,000 shares $58.44 million -8.7%N/A6.3 $3.97 5/31/202416,120,000 shares $55.29 million -5.4%N/A6.7 $3.43 5/15/202417,040,000 shares $52.99 million +0.8%N/A6.4 $3.11 4/30/202416,910,000 shares $41.09 million +5.2%N/A6.1 $2.43 4/15/202416,070,000 shares $42.75 million -5.4%N/A5.9 $2.66 3/31/202416,990,000 shares $48.76 million +7.5%N/A6.1 $2.87 3/15/202415,810,000 shares $36.36 million +13.9%N/A6 $2.30 2/29/202413,880,000 shares $43.86 million -14.9%N/A6.3 $3.16 2/15/202416,300,000 shares $25.92 million -2.9%N/A8.3 $1.59 1/31/202416,780,000 shares $25.51 million -4.1%N/A8 $1.52 1/15/202417,490,000 shares $27.98 million -0.2%N/A7.8 $1.60 12/31/202317,530,000 shares $31.03 million +2.3%N/A7.8 $1.77 12/15/202317,130,000 shares $27.92 million +6.0%N/A8.2 $1.63 11/30/202316,160,000 shares $28.44 million +15.8%N/A7.6 $1.76Protect Your Bank Account with THESE 4 Simple Steps (Ad)Starting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.Learn these 4 simple steps and protect your savings before it’s too late. 11/15/202313,950,000 shares $23.44 million +42.9%N/A5.6 $1.68 10/31/20239,760,000 shares $22.84 million -2.6%N/A1.8 $2.34 10/15/202310,020,000 shares $22.65 million -6.1%N/A1.9 $2.26 9/30/202310,670,000 shares $33.72 million +7.5%N/A2.1 $3.16 9/15/20239,930,000 shares $32.67 million +34.9%N/A2.1 $3.29 8/31/20237,360,000 shares $23.55 million +902.0%N/A1.6 $3.20 8/15/2023734,500 shares $1.60 million -33.2%3.9%0.2 $2.18 7/31/20231,100,000 shares $740.52 thousand -1.8%3.0%4.4 $0.67 7/15/20231,120,000 shares $773.92 thousand -12.5%3.1%4.3 $0.69 6/30/20231,280,000 shares $846.08 thousand -10.5%3.5%4 $0.66 6/15/20231,430,000 shares $1.09 million +16.3%3.8%3.7 $0.77 5/31/20231,230,000 shares $859.65 thousand +3.4%3.4%3.2 $0.70 5/15/20231,190,000 shares $824.79 thousand -31.2%3.2%3 $0.69 4/30/20231,730,000 shares $1.34 million +6.1%4.7%4.1 $0.78 4/15/20231,630,000 shares $1.42 million -15.5%4.5%2.9 $0.87 3/31/20231,930,000 shares $1.54 million -18.2%5.4%3.5 $0.80 3/15/20232,360,000 shares $2.07 million -11.6%6.5%4.4 $0.88 2/28/20232,670,000 shares $2.70 million +19.7%7.3%4.7 $1.01 2/15/20232,230,000 shares $2.41 million +2.3%6.1%3.7 $1.08 1/31/20232,180,000 shares $3.58 million +26.7%6.0%2.7 $1.64 1/15/20231,720,000 shares $3.96 million +25.6%4.7%0.7 $2.30 12/30/20221,370,000 shares $3.10 million +48.0%3.8%0.5 $2.26 12/15/2022925,700 shares $2.13 million +12.3%2.5%0.4 $2.30 11/30/2022824,500 shares $1.82 million -38.5%3.8%0.3 $2.21 11/15/20221,340,000 shares $2.95 million -19.8%6.3%0.6 $2.20 10/31/20221,670,000 shares $2.87 million +73.8%11.3%0.8 $1.72 10/15/2022960,700 shares $1.53 million +8.0%4.1%0.6 $1.59 9/30/2022889,600 shares $1.72 million -5.2%3.8%8.5 $1.93 9/15/2022938,700 shares $2.92 million +5.2%4.0%6.2 $3.11 8/31/2022892,600 shares $2.82 million +3.5%3.8%5.3 $3.16 8/15/2022862,300 shares $3.74 million -7.2%3.7%4 $4.34 7/31/2022929,100 shares $3.78 million -10.7%4.1%3.8 $4.07 7/15/20221,040,000 shares $4.43 million -13.3%4.5%3.9 $4.26 6/30/20221,200,000 shares $4.46 million -26.4%5.2%3.8 $3.72 6/15/20221,630,000 shares $4.91 million -3.6%7.1%4.9 $3.01 5/31/20221,690,000 shares $4.31 million -4.5%7.7%6 $2.55 5/15/20221,770,000 shares $6.09 million +18.0%8.1%6.5 $3.44 4/30/20221,500,000 shares $5.49 million +19.1%7.2%5.4 $3.66 4/15/20221,260,000 shares $6.98 million -64.6%6.1%4.5 $5.54 3/31/20223,560,000 shares $23.21 million +4.1%17.1%15.3 $6.52 3/15/20223,420,000 shares $18.30 million +0.6%16.4%15.9 $5.35 2/28/20223,400,000 shares $21.66 million -6.6%16.4%15.3 $6.37 2/15/20223,640,000 shares $28.50 million +10.0%17.5%17 $7.83 1/31/20223,310,000 shares $26.31 million +9.2%15.9%16.2 $7.95 1/15/20223,030,000 shares $28.88 million +0.7%13.9%15.6 $9.53 12/31/20213,010,000 shares $35.07 million +18.0%14.3%16.8 $11.65 12/15/20212,550,000 shares $36.31 million -1.5%12.1%14.9 $14.24 11/30/20212,590,000 shares $33.62 million +1.2%12.3%17.7 $12.98 11/15/20212,560,000 shares $37.12 million +6.7%12.2%18.4 $14.50 10/29/20212,400,000 shares $37.54 million -4.4%11.0%19.7 $15.64Protect Your Bank Account with THESE 4 Simple Steps (Ad)Starting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.Learn these 4 simple steps and protect your savings before it’s too late. 10/15/20212,510,000 shares $44.88 million -11.3%11.6%27 $17.88 9/30/20212,830,000 shares $52.69 million +3.7%13.0%28.3 $18.62 9/15/20212,730,000 shares $57.00 million No Change12.6%17.6 $20.88 8/31/20212,730,000 shares $54.27 million -0.4%12.7%16.6 $19.88 8/13/20212,740,000 shares $47.62 million -0.7%12.6%14.3 $17.38 7/30/20212,760,000 shares $47.72 million +10.8%12.8%14.1 $17.29 7/15/20212,490,000 shares $48.88 million +31.1%11.6%12.9 $19.63 6/30/20211,900,000 shares $40.28 million +37.7%9.8%9.9 $21.20 6/15/20211,380,000 shares $35.85 million -11.5%6.9%9.7 $25.98 5/28/20211,560,000 shares $35.10 million +9.9%7.8%12.7 $22.50 5/14/20211,420,000 shares $29.71 million +5.2%7.1%14.7 $20.92 4/30/20211,350,000 shares $33.75 million +2.3%6.8%16.6 $25.00 4/15/20211,320,000 shares $33.75 million -7.7%6.7%16.4 $25.57 3/31/20211,430,000 shares $29.32 million +7.5%7.2%16.5 $20.50 3/15/20211,330,000 shares $35.98 million +2.3%6.7%12.6 $27.05 2/26/20211,300,000 shares $34.93 million No Change6.6%11.1 $26.87 2/12/20211,300,000 shares $39.55 million +13.0%6.9%11 $30.42 1/29/20211,150,000 shares $33.27 million -8.7%14.9%9.3 $28.93 1/15/20211,260,000 shares $36.16 million No Change16.3%9.4 $28.70 TSHA Short Interest - Frequently Asked Questions What is Taysha Gene Therapies' current short interest? Short interest is the volume of Taysha Gene Therapies shares that have been sold short but have not yet been covered or closed out. As of July 15th, investors have sold 43,960,000 shares of TSHA short. Learn More on Taysha Gene Therapies' current short interest. What is a good short interest ratio for Taysha Gene Therapies? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. TSHA shares currently have a short interest ratio of 11.0. Learn More on Taysha Gene Therapies's short interest ratio. Which institutional investors are shorting Taysha Gene Therapies? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Taysha Gene Therapies: Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Taysha Gene Therapies' short interest increasing or decreasing? Taysha Gene Therapies saw a increase in short interest during the month of July. As of July 15th, there was short interest totaling 43,960,000 shares, an increase of 2,952.8% from the previous total of 1,440,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Taysha Gene Therapies' short interest compare to its competitors? Here is how the short interest of companies compare to Taysha Gene Therapies: Howard Hughes Holdings Inc. (3.93%), Beam Therapeutics Inc. (23.39%), Arrowhead Pharmaceuticals, Inc. (8.99%), Twist Bioscience Corporation (17.81%), Harmony Biosciences Holdings, Inc. (10.20%), IDEAYA Biosciences, Inc. (14.90%), Disc Medicine, Inc. (13.44%), Mesoblast Limited (2.13%), Centessa Pharmaceuticals PLC Sponsored ADR (4.29%), Vericel Corporation (10.60%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Coinbase Global, Inc. ($5.11 billion), Charter Communications, Inc. ($4.76 billion), Reddit Inc. ($2.84 billion), SoFi Technologies, Inc. ($2.79 billion), Seagate Technology Holdings PLC ($2.79 billion), Live Nation Entertainment, Inc. ($2.67 billion), Rocket Lab Corporation ($2.49 billion), AST SpaceMobile, Inc. ($2.12 billion), Moderna, Inc. ($2.09 billion), and Omnicom Group Inc. ($2.04 billion). View all of the most shorted stocks. What does it mean to sell short Taysha Gene Therapies stock? Short selling TSHA is an investing strategy that aims to generate trading profit from Taysha Gene Therapies as its price is falling. TSHA shares are trading down $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Taysha Gene Therapies? A short squeeze for Taysha Gene Therapies occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of TSHA, which in turn drives the price of the stock up even further. How often is Taysha Gene Therapies' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TSHA, twice per month. The most recent reporting period available is July, 15 2025. More Short Interest Resources from MarketBeat Related Companies HHH Short Squeeze BEAM Short Squeeze ARWR Short Squeeze TWST Short Squeeze HRMY Short Squeeze IDYA Short Squeeze IRON Short Squeeze MESO Short Squeeze CNTA Short Squeeze VCEL Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:TSHA) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredCritical AI announcement set to ignite AI 2.0 A new 100% tariff on imported chips just rattled the tech sector—sending some stocks soaring and others tumbli...Timothy Sykes | SponsoredTrump’s new nightmareAccording to Porter Stansberry and Jeff Brown, a government-led financial mobilization is already reshaping Am...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Taysha Gene Therapies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Taysha Gene Therapies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
